| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anergy: the CLL cell limbo
|
Caligaris-Cappio, Federico
|
|
|
123 |
21 |
p. 3214-3215
|
artikel
|
| 2 |
A rare cause of lymphocytosis
|
Olsen, Brian
|
|
|
123 |
21 |
p. 3219
|
artikel
|
| 3 |
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias
|
Dubrovsky, Leonid
|
|
|
123 |
21 |
p. 3296-3304
|
artikel
|
| 4 |
Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children
|
Atkinson, Sarah H.
|
|
|
123 |
21 |
p. 3221-3229
|
artikel
|
| 5 |
Cruz CRY, Micklethwaite KP, Savoldo B, et al. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013;122(17):2965-2973.
|
|
|
|
123 |
21 |
p. 3364
|
artikel
|
| 6 |
Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia
|
Wang, Changshan
|
|
|
123 |
21 |
p. 3336-3343
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
123 |
21 |
p. i
|
artikel
|
| 8 |
Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice
|
Morioka, Yoko
|
|
|
123 |
21 |
p. 3344-3353
|
artikel
|
| 9 |
Frede S, Freitag P, Geuting L, Konietzny R, Fandrey J. Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC. Blood. 2011;117(18):
|
|
|
|
123 |
21 |
p. 3365
|
artikel
|
| 10 |
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
|
Geisler, Christian H.
|
|
|
123 |
21 |
p. 3255-3262
|
artikel
|
| 11 |
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
|
Stilgenbauer, Stephan
|
|
|
123 |
21 |
p. 3247-3254
|
artikel
|
| 12 |
GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice
|
Le Behot, Audrey
|
|
|
123 |
21 |
p. 3354-3363
|
artikel
|
| 13 |
Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 2013;122(24):3879-3883.
|
|
|
|
123 |
21 |
p. 3364
|
artikel
|
| 14 |
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL
|
Herman, Sarah E.M.
|
|
|
123 |
21 |
p. 3286-3295
|
artikel
|
| 15 |
Ibrutinib: targeting the hidden CLL
|
Awan, Farrukh T.
|
|
|
123 |
21 |
p. 3215-3216
|
artikel
|
| 16 |
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
|
Shah, Dimpy P.
|
|
|
123 |
21 |
p. 3263-3268
|
artikel
|
| 17 |
Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. Blood. 2013;122(14):2453-2459.
|
|
|
|
123 |
21 |
p. 3364
|
artikel
|
| 18 |
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
|
Gu, Yanyan
|
|
|
123 |
21 |
p. 3269-3276
|
artikel
|
| 19 |
Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas
|
Graus, Francesc
|
|
|
123 |
21 |
p. 3230-3238
|
artikel
|
| 20 |
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
|
Lancet, Jeffrey E.
|
|
|
123 |
21 |
p. 3239-3246
|
artikel
|
| 21 |
Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition
|
Ng, King Pan
|
|
|
123 |
21 |
p. 3316-3326
|
artikel
|
| 22 |
Plasmacytoid dendritic cells in chronic myelomonocytic leukemia
|
Ji, Peng
|
|
|
123 |
21 |
p. 3220
|
artikel
|
| 23 |
Predicting treatment outcomes in CLL
|
Wiestner, Adrian
|
|
|
123 |
21 |
p. 3212-3214
|
artikel
|
| 24 |
Reason for CPXcitement in AML
|
Zeidner, Joshua F.
|
|
|
123 |
21 |
p. 3211-3212
|
artikel
|
| 25 |
Saha A, Aoyama K, Taylor PA, et al. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. 3062-3073.
|
|
|
|
123 |
21 |
p. 3364
|
artikel
|
| 26 |
Splicing factor mutations in AML
|
Ogawa, Seishi
|
|
|
123 |
21 |
p. 3216-3217
|
artikel
|
| 27 |
The iron fist: malaria and hepcidin
|
Mohandas, Narla
|
|
|
123 |
21 |
p. 3217-3218
|
artikel
|
| 28 |
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
|
Hope, Chelsea
|
|
|
123 |
21 |
p. 3305-3315
|
artikel
|
| 29 |
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling
|
Taskesen, Erdogan
|
|
|
123 |
21 |
p. 3327-3335
|
artikel
|
| 30 |
Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy
|
Duckworth, Andrew
|
|
|
123 |
21 |
p. 3277-3285
|
artikel
|
| 31 |
Webber BR, Iacovino M, Choi SH, Tolar J, Kyba M, Blazar BR. DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood. 2013;122(17):2978-2986.
|
|
|
|
123 |
21 |
p. 3364
|
artikel
|
Tijdschrift beschrijving